Andrew Crofton is a founder and a member of the board of directors of  Karamedica.

Dr. Crofton is an emerging leader in chitosan research and manipulation as it relates to medicine. He obtained a B.A. in Chemistry and Religion with a Biomedical Studies Concentration from St. Olaf College in 2009. He then completed Loma Linda University School of Medicine’s Integrated Biomedical Graduate Studies PhD program with emphasis in clinical anatomy in 2015 before joining the faculty of Adventist University of Health Sciences. He has 8 years experience in chitosan research, decontamination, and nitrogen plasma sterilization/depyrogenation. Dr. Crofton is the co-inventor on 5 patents or pending patents related to chitosan and Alzheimer’s disease. He is also an experienced leader having served as a mentor for small businesses in the National Science Foundation’s Innovation Corps (I-Corps) and president of several non-profit organizations.